 1. Compare the safety and tolerability of four dose levels of ACAM2000 and a standard dose of Dryvax in healthy adults at least 28 years of age and previously vaccinated to smallpox. Safety and tolerability will be determined by examination of the local cutaneous reaction, adverse events, physical examinations, vital signs, structured interviews, and laboratory analysis. 